Uni-Pharma's head offices and manufacturing facilities are located in Kiﬁssia, a northern suburb of the bustling city of Athens.
Since its foundation, 52 years ago, Uni-Pharma has grown from a small privately held company into a large and dynamic company, which currently holds the ﬁrst position in unit sales among companies in the Greek pharmaceutical market. Uni-Pharma researches, develops, manufactures, markets and distributes pharmaceuticals, nutritional products and medical devices. Uni-Pharma's dynamic growth is based on investments in research and development, as well as on a working style, designed to develop staﬀ skills and to encourage individual contribution and creativity. The production capacity exceeds 21 million pieces annually, making the UNI-PHARMA the first Greek company in unit sales in the Greek market.
Uni-Pharma's prime objective is to ensure long-term growth solely through its own resources, develop its technological capabilities and become independent of external resources. To achieve this objective, the company strives to ensure a balanced and steady development of its human and technological resources.
Uni-Pharma's main goal is to achieve the entrance in new markets by producing innovative products.